According to the company, it "is designed to mimic many of the physiological effects of fasting improved insulin sensitivity, reduced fat mass and more efficient energy metabolism without requiring significant changes in feeding routines or disrupting the human-animal bond that often centers around food." It has the potential to improve a cat's quality of life and support healthy aging
In 2021 - 2022, a stronger dose, weekly injectable formulation of Semaglutide (brand name Wegovy) was approved by the US FDA as a medication for weight loss in patients with at least one weight related medical issue
B12 deficiency is a known concern with long-term GLP-1 therapy, particularly because many researchers are simultaneously reducing their caloric intake
GHK-Cu upregulates several tumor suppressor genes (caspases, growth arrest and DNA damage-inducible genes) and downregulates genes associated with metastasis, invasion, and angiogenesis
Many products on the market contain synthetic fillers, artificial colors, or ingredients that are not sustainably sourced